Nu Skin Enterprises, Inc. (NYSE:NUS)’s share price traded down 7.5% during trading on Monday following insider selling activity. The company traded as low as $54.68 and last traded at $56.01, with a volume of 2,902,381 shares trading hands. The stock had previously closed at $60.52.

Specifically, President Ryan S. Napierski sold 8,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $65.00, for a total transaction of $520,000.00. Following the transaction, the president now directly owns 68,170 shares of the company’s stock, valued at $4,431,050. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel D Matthew Dorny sold 7,500 shares of Nu Skin Enterprises stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $60.88, for a total transaction of $456,600.00. Following the transaction, the general counsel now directly owns 52,230 shares in the company, valued at $3,179,762.40. The disclosure for this sale can be found here. Insiders have sold 31,750 shares of company stock worth $1,946,810 over the last three months. Insiders own 5.20% of the company’s stock.

Several research analysts have commented on the stock. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. BidaskClub downgraded shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Bank of America Corporation lifted their price target on shares of Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a research note on Monday, July 10th. Pivotal Research reissued a “buy” rating and set a $80.00 price target (up from $65.00) on shares of Nu Skin Enterprises in a research note on Thursday, June 22nd. Finally, Stifel Nicolaus set a $50.00 price target on shares of Nu Skin Enterprises and gave the stock a “sell” rating in a research note on Thursday, August 3rd. Two analysts have rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $62.88.

The stock has a market cap of $2.84 billion, a P/E ratio of 17.96 and a beta of 1.31. The company has a 50-day moving average of $62.36 and a 200 day moving average of $56.55.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.69 by $0.08. The business had revenue of $550.10 million during the quarter, compared to analysts’ expectations of $548.09 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The company’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same period last year, the firm earned $0.79 EPS. On average, analysts anticipate that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Friday, August 25th will be issued a $0.36 dividend. The ex-dividend date of this dividend is Wednesday, August 23rd. This represents a $1.44 annualized dividend and a dividend yield of 2.68%. Nu Skin Enterprises’s dividend payout ratio is currently 48.81%.

Several hedge funds have recently bought and sold shares of the stock. Creative Planning boosted its stake in Nu Skin Enterprises by 38.5% in the first quarter. Creative Planning now owns 1,800 shares of the company’s stock valued at $100,000 after buying an additional 500 shares in the last quarter. US Bancorp DE boosted its stake in Nu Skin Enterprises by 3.3% in the second quarter. US Bancorp DE now owns 2,032 shares of the company’s stock valued at $128,000 after buying an additional 65 shares in the last quarter. TrimTabs Asset Management LLC boosted its stake in Nu Skin Enterprises by 88.7% in the first quarter. TrimTabs Asset Management LLC now owns 2,349 shares of the company’s stock valued at $130,000 after buying an additional 1,104 shares in the last quarter. Independent Portfolio Consultants Inc. boosted its stake in Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock valued at $132,000 after buying an additional 40 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Nu Skin Enterprises by 23.0% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,506 shares of the company’s stock valued at $139,000 after buying an additional 468 shares in the last quarter. 84.53% of the stock is owned by institutional investors and hedge funds.

WARNING: This article was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/08/16/nu-skin-enterprises-inc-nus-shares-down-7-5-following-insider-selling.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Receive News & Stock Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related stocks with our FREE daily email newsletter.